C.r.a.Pu. Seminar
by researcher Giovanni Puccio
Русский
italiano
Español
Information
The seminar will be held at the end of January and will be available only to Contributing Members. Register now.
C.R.A.PU. Terapy
CRAPU (Puccio’s Complementary Anti-degenerative Reducing Therapy) is a biochemical approach that does not cure any disease.
Its purpose is to restore cellular redox balance, which is compromised by chronic oxidative stress.
In practice:
– it reduces the excess of peroxides and free radicals
– it reactivates key enzymes (catalase, glutathione-ascorbate system)
– it unblocks fundamental processes such as methylation and cellular defense
By doing so:
– the immune system becomes biologically efficient again
– the organism recovers a rapid and effective response capacity, observed by many doctors as superior to that obtainable with official protocols alone.
CRAPU does not replace medical therapies:
it makes them biochemically possible.
Audio Podcast
GIOVANNI PUCCIO:
Learning the “CraPu” procedure to save lives
Giovanni Puccio is an expert in basic structural chemistry, a field in which he has worked since 1977, and an independent researcher from Palermo focused on the etiopathogenesis of degenerative diseases. His oncology research began in 1992, driven by the desire to understand the biochemical mechanisms behind the formation of infiltrating tumors and their ability to evade the immune system.
Below are the key points that define his profile and work:
-
Creator of C.R.A.Pu. Therapy: He developed the Complementary Reducing Anti-Degenerative Puccio Therapy, a method aimed at restoring cellular redox balance and eliminating persistent oxidative stress, considered the common basis of many chronic diseases.
-
Scientific Contribution and Collaborations: Although often described as a “self-taught” researcher, his work has received recognition from prestigious institutions. Puccio appears as a co-author in several scientific publications indexed on PubMed, resulting from collaborations with the University Hospital of Zurich, Sant’Orsola Hospital in Bologna, and the Multimedica Center in Milan.
-
Research on RNA Viruses and COVID-19: He theorized that RNA virus replication is linked to dysfunctions in the methylation process and the glutathione cycle. During the pandemic, his integrated protocol was successfully applied by home-care physicians to treat hundreds of patients, drastically reducing hospitalizations.
-
Study on mRNA Vaccine Injuries: He conducted research on the potential adverse effects of mRNA vaccines, noting that persistence of the Spike protein may block crucial enzymes and cause neurological or cardiac damage. To counter these effects, he strengthened the CRAPU therapy to promote degradation of synthetic mRNA.
-
Institutional and Social Commitment: He is co-founder of the Scientific Research Association “EMMANUELE”, established in 2003 to protect his discoveries and promote the right to medical care. His theories have been the subject of parliamentary inquiries in Italy and collaboration agreements with international organizations such as the National Foundation for Alternative Medicine in Washington.
Some Results Achieved by Physicians Trained by Giovanni Puccio
A Sicilian patient, diagnosed in 2004 with end-stage squamous cell lung carcinoma and sent home to die, was later declared completely cured by physicians after being successfully treated using the biochemical approach developed by researcher Puccio.
A documented case involved a patient with glioblastoma, an extremely aggressive brain tumor, who achieved a 57% reduction in tumor mass in just four months of treatment.
A general practitioner reported having successfully treated about 1,200 patients infected with SARS-CoV-2 by integrating the principles of CRAPU therapy into a home-care protocol, with only three total hospitalizations recorded.
Diversi medici operanti sul territorio hanno documentato miglioramenti clinici significativi in pazienti che presentavano paralisi, parestesie e problemi neurologici attribuiti alla persistenza della proteina Spike, grazie all’uso di una versione potenziata della terapia CRAPU specifica per degradare l’mRNA sintetico
Zoom Meeting Request with the Researcher
A collaboration
between the Emanuele Association
and the BuonSenso Club
